Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1

Conditions

Pancreatic Neoplasms 153Carcinoma, Non-Small-Cell Lung 94Neoplasms 57Breast Neoplasms 50Urinary Bladder Neoplasms 47Neoplasm Metastasis 43Lung Neoplasms 41Ovarian Neoplasms 36Cholangiocarcinoma 31Lymphoma 20Sarcoma 19Gallbladder Neoplasms 19Fallopian Tube Neoplasms 19Lymphoma, Large B-Cell, Diffuse 18Biliary Tract Neoplasms 18Recurrence 15Lymphoma, Non-Hodgkin 15Adenocarcinoma 14Hodgkin Disease 13Carcinoma, Transitional Cell 13Bile Duct Neoplasms 13Carcinoma 12Colorectal Neoplasms 10Head and Neck Neoplasms 8Carcinoma, Renal Cell 8Urethral Neoplasms 7Parkinson Disease 4, Autosomal Dominant Lewy Body 7Carcinoma, Ovarian Epithelial 7Adenocarcinoma of Lung 7Uterine Cervical Neoplasms 6

Interventions

Paclitaxel 6Radiotherapy 2Pemetrexed 2Carboplatin 2Brachytherapy 2tucatinib 1seribantumab 1osimertinib 1gedatolisib 1fosaprepitant 1fluciclovine F-18 1cobimetinib 1atezolizumab 1alovudine 1Trastuzumab 1Therapeutics 1TP protocol 1Saline Solution 1Radiation 1Protons 1Palliative Care 1Nivolumab 1Letrozole 1Immunoglobulin G 1Imatinib Mesylate 1Ifosfamide 1Gemcitabine 1Fulvestrant 1FANG vaccine 1Everolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Uterine Neoplasms × Gemcitabine × Clear all
NCT00282087 2014-12-01

Adjuvant Chemotherapy for High Risk Uterine Leiomyosarcoma

Sarcoma Alliance for Research through Collaboration

Phase 2 Completed
47 enrolled 16 charts
GynecologicSarcoma

Leiomyosarcoma, Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡